RG
PFE icon

Redmile Group’s Pfizer PFE Stock Holding History

Redmile Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-130,485
Closed -$3.67M – 57
2016
Q1 		$3.67M Hold
130,485
– – 0.38% 37
2015
Q4 		$4M Buy
+130,485
New +$4.1M 0.3% 42
2014
Q1 		– Sell
-564,944
Closed -$16.4M – 64
2013
Q4 		$16.4M Buy
+564,944
New +$16.4M 2.03% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Redmile Group's PFE Position: Q2 2016 in Review

Redmile Group sold out of Pfizer (PFE) in Q2 2016, closing a stake of 130,485 shares — an estimated $3.67M sold.

Redmile Group first reported a position in PFE in Q4 2013 and held it in 3 quarters. The position peaked at $16.4M in Q4 2013. 1,993 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Redmile Group reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Redmile Group sold 130,485 Pfizer shares in Q2 2016, an estimated $3.67M.
  • Redmile Group first reported a position in Pfizer in Q4 2013 and held it in 3 quarters.
  • Redmile Group's Pfizer position peaked at $16.4M in Q4 2013.
  • 1,993 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Redmile Group's 13F filing for Q2 2016, filed 16 Aug 2016.